Insulin initiation in India is often delayed due to fear of injections & pain, treatment complexity & adherence concerns. Awiqli promises to reduce no of injections from 365 a year to 52.
Nordisk’s India managing director told ThePrint, his company has now moved to higher-dose Semaglutide, oral formulations and two new therapies which are advancing as cardiometabolic care.
India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, according to market estimates.
While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its effectiveness in obesity management come out in 3 months.
ThePrint has learnt that more than one woman fighter pilot were involved in targeting military locations during the 87-hour conflict with Pakistan last year.
Forty years ago this week, ‘Khalistan Commando Force’ assassins were closing in on Gen Vaidya. So callous was the security of the just-retired Army chief that he was given a solitary police gunman
COMMENTS